CCR5 antagonist maraviroc alleviates doxorubicin-induced neuroinflammation and neurobehavioral deficiency by regulating NF-κB/NLRP3 signaling in a breast cancer mouse model
Yuanyuan Wu, Ji Che, Jing Dong, Xiang Zhang, Yixu Deng, Wei Chen, Jun Zhang, Jun Zhang
Topics & Concepts
MaravirocCCR5 receptor antagonistPharmacologyProinflammatory cytokineNeuroinflammationMorris water navigation taskMedicineDoxorubicinChemokineChemistryImmunologyChemokine receptorInternal medicineInflammationHippocampusChemotherapyHuman immunodeficiency virus (HIV)Cancer-related cognitive impairment studiesIntensive Care Unit Cognitive DisordersGlioma Diagnosis and Treatment